trending Market Intelligence /marketintelligence/en/news-insights/trending/_8NdmaRxSYRYkXybFucruw2 content esgSubNav
In This List

Transgenomic, Precipio merger secures stockholder approval

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Transgenomic, Precipio merger secures stockholder approval

Transgenomic Inc. received stockholder approval for its proposed merger with Precipio Diagnostics LLC.

Precipio Diagnostics stockholders also approved the deal.

The closing of the merger is still pending the combined company's $7 million private placement of preferred convertible securities and the conversion of all outstanding secured debt into preferred convertible securities.

The combined company will be renamed Precipio Inc. and be relisted on Nasdaq under the PRPO ticker symbol.